Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
ADAMTS-5: The story so far
ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain
ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis
ADAMTS-1/METH-1 and TIMP-3 expression in the primate corpus luteum: divergent patterns and stage-dependent regulation during the natural menstrual cycle
ADAMTSL6 beta Protein Rescues Fibrillin-1 Microfibril Disorder in a Marfan Syndrome Mouse Model through the Promotion of Fibrillin-1 Assembly
ADAMTS10 Protein Interacts with Fibrillin-1 and Promotes Its Deposition in Extracellular Matrix of Cultured Fibroblasts
ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment
ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
ADAMTS-7 Exhibits Elevated Expression in Cartilage of Osteonecrosis of Femoral Head and Has a Positive Correlation with TNF-alpha and NF-kappa B P65
ADAM-9 expression and regulation in human skin melanoma and melanoma cell lines
ADAM proteins in the brain
ADAM17 as a Therapeutic Target in Multiple Diseases
ADAM function in embryogenesis
ADAM17: a molecular switch to control inflammation and tissue regeneration
ADAMTSL3 as a candidate gene for schizophrenia: Gene sequencing and ultra-high density association analysis by imputation
ADAMTS-12 Metalloprotease Is Necessary for Normal Inflammatory Response
ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma
ADAM17 Controls Endochondral Ossification by Regulating Terminal Differentiation of Chondrocytes
ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis
ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status?
ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
ADAMTS9 Is a Cell-Autonomously Acting, Anti-Angiogenic Metalloprotease Expressed by Microvascular Endothelial Cells
ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices
ADAMTS5 Functions as an Anti-Angiogenic and Anti-Tumorigenic Protein Independent of Its Proteoglycanase Activity
ADAMTS13, von Willebrand factor specific cleaving protease
ADAMTS13 assays and ADAMTS13-deficient mice
ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions
ADAMTS13 turns 3
ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences
ADAMTS-13 is a metalloprotease that regulates platelet aggregation in hemostasis
ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor
ADAMTS13 Mutations and Polymorphisms in Congenital Thrombotic Thrombocytopenic Purpura
ADAMTS13 and thrombotic thrombocytopenic purpura Retrospective study at the hospital of Le Mans
ADAMs: modulators of cell-cell and cell-matrix interactions
ADAMs in cancer cell proliferation and progression
ADAM10 Regulates Transcription Factor Expression Required for Plasma Cell Function
ADAM10 Overexpression Shifts Lympho- and Myelopoiesis by Dysregulating Site 2/Site 3 Cleavage Products of Notch
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis
ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation
ADAMTS13 is expressed in hepatic stellate cells
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
ADAMTS13 content and VWF multimer and triplet structure in commercially available VWF/FVIII concentrates
ADAMTS13 substrate recognition of von Willebrand factor A2 domain
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus
ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction
ADAMTS13 Gene Mutations in Children with Hemolytic Uremic Syndrome
ADAMTS13 activity and genetic mutations in Japan
ADAM17 at the interface between inflammation and autoimmunity
ADAMTS Metalloproteases Generate Active Versican Fragments that Regulate Interdigital Web Regression
ADAM-17/Tumor Necrosis Factor-alpha-Converting Enzyme Inhibits Neurogenesis and Promotes Gliogenesis from Neural Stem Cells
ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat
ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-alpha Dependent and Promotes Glioblastoma Cell Migration
ADAM-15: a metalloprotease that mediates inflammation
ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma
ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deterioration
ADAM proteases: ligand processing and modulation of the Notch pathway
ADAM gene expression and regulation during human osteoclast formation
ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion
ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers
ADAM 10: An active metalloprotease expressed during avian epithelial morphogenesis
ADAMTS: a novel family of extracellular matrix proteases
ADAMTS9, a novel member of the ADAM-TS/metallospondin gene family
ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alpha v beta 3 integrin through an RGD-independent mechanism
ADAMTS-13 IN CRITICALLY ILL PATIENTS WITH SEPTIC SYNDROMES AND NONINFECTIOUS SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
ADAM10 in Synaptic Physiology and Pathology
ADAM 13: A novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development
ADAMs: Targets for Drug Discovery
ADAM8 substrate specificity: Influence of pH on pre-processing and proteoglycan degradation
ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia
ADAM15 to alpha 5 beta 1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis
ADAM15 Protein Amplifies Focal Adhesion Kinase Phosphorylation under Genotoxic Stress Conditions
ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation
ADAMTS13 exerts a thrombolytic effect in microcirculation
ADAMTS7 in Cardiovascular Disease From Bedside to Bench and Back Again?
ADAMTS13-marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis
ADAM33 genetic polymorphisms and risk of atopic dermatitis among Japanese children
ADAM17, shedding, TACE as therapeutic targets
ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by gamma-secretase
ADAM17 Activity and Other Mechanisms of Soluble L-selectin Production during Death Receptor-Induced Leukocyte Apoptosis
ADAMTS13 Deficiency with Elevated Levels of Ultra-Large and Active von Willebrand Factor in P. falciparum and P. vivax Malaria
ADAM17 promotes glioma cell malignant phenotype